ULCOFIN Suspension

Drug Category H-2 Receptor Blocker

MECHANISM OF ACTION Famotidine binds competitively to H₂-receptors located on the parietal cell, blocking histamine affects. This competitive inhibition results in reduced basal and nocturnal gastric acid secretion and a reduction in gastric volume, acidity, and amount of gastric acid released.

INDICATIONS Gastric ulcers, Duodenal ulcers, Reflux oesophagitis, Chronic episodic dyspepsia and other pathological hypersecretory states e.g., Zollinger-Ellison Syndrome. ULCOFIN Suspension is indicated for the relief of heart burn /acid indigestion and prevention of these symptoms caused by acid related diseases.

DOSAGE AND ADMINISTRATION Benign gastric & duodenal ulcers: 40mg one tablet at night for 4-8 weeks, maintenance therapy is 20mg one tablet once daily. GERD: 20mg to 40mg one tablet twice daily for 6-12 weeks, Zollinger-Ellison syndrome: Initially 20mg one tablet 6 hourly. ULCOFIN Suspension: Bening gastric & duodenal ulcers: 4 teaspoonful at night for 4-8 weeks, maintenance therapy is 2 teaspoonfuls once daily. GERD: 2 to 4 teaspoonfuls twice daily for 6-12 weeks. Zollinger-Ellison syndrome: 2 teaspoonfuls 6 hourly

Presentation Ulcofin suspension is available in the glass bottle of 120ml